Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Lyophilisation (Freeze-Drying) Contract Manufacturing

Freeze-dried injectables in vials, made under your brand by sterile manufacturing sites in India with validated lyophilisation lines.

Freeze-drying protects products that are unstable in solution

Lyophilisation, or freeze-drying, removes water from a frozen product under vacuum, leaving a dry cake in the vial that is dissolved just before use. It is used for products that break down in solution, such as proton pump inhibitor injections, many oncology drugs, peptides, vaccines and other biologics.

Every product needs its own cycle of freezing, primary drying and secondary drying, developed in the laboratory and then proven at commercial scale. The cycle decides the cake's appearance, its residual moisture and how quickly it dissolves. Freeze-dryer time is also a common bottleneck, because cycles can take days and each dryer runs one load at a time.

We shortlist sterile sites that already freeze-dry products like yours and have validated cycles, freeze-dryer capacity and the inspections your market needs.

Tell us this to get a quote

  • Molecule(s) and strength per vial
  • Existing formula and cycle, or development needed
  • Vial size and fill volume
  • Diluent supplied with the product, or not
  • Target market(s)
  • Annual volume and first-order quantity
  • Special handling: cytotoxic, hormone or beta-lactam

What to check in a freeze-drying manufacturer

Cycle development and scale-up

Who owns the cycle, how it was transferred from laboratory to commercial scale, and the validation batches behind it.

Moisture and cake quality

Residual moisture limits, cake appearance (collapse or shrinkage) and reconstitution time, at release and at the end of shelf life.

Freeze-dryer capacity

How many freeze-dryers the site has, their size, and how your batches will be scheduled alongside other customers.

Aseptic loading

Partially stoppered vials are moved into the freeze-dryer under aseptic conditions. Ask how loading and unloading are protected and covered by media fills.

Stoppering and container integrity

Vials are usually stoppered inside the freeze-dryer under vacuum or nitrogen. Ask for container closure integrity data for the vial and stopper used.

Stability and storage

Stability data for your climatic zone, in-use stability after reconstitution, and storage needs, which can include refrigeration.

Products often supplied freeze-dried

Product typeExamplesWatch for
Proton pump inhibitor injectionsPantoprazole, esomeprazoleAlkaline solution, reconstitution time
Oncology productsBortezomib, azacitidine, gemcitabineContainment for cytotoxic products
Antibiotics and antifungalsVancomycin, caspofungin, micafunginRefrigerated storage for some products
Peptides and hormonesBivalirudin, glucagon emergency kitsLow fill weights, moisture sensitivity
Biologics and vaccinesSome monoclonal antibodies and vaccinesPotency, cold chain, specialised sites

Not every molecule needs freeze-drying. Some injectables are filled as sterile powder or as a ready-made solution instead, which is usually cheaper. We check which route fits your product and registration.

How it works with PharmaTradz

1
Brief

You send the product, form, market and volume.

2
Shortlist with approvals

Two or three plants that already make that type of product, with their approvals and country of manufacture. Names under a confidential disclosure agreement when the requirement is firm.

3
Samples and development

Samples of an existing product, or cycle development and stability batches for a new one.

4
Artwork and registration

Your brand, artwork and pack, and the dossier your market needs.

5
Commercial batches

Production and release with a batch-wise Certificate of Analysis, sterility, endotoxin and moisture results. Cold-chain shipping where needed.

6
Repeat supply

Scheduled batches with the same site, materials and documents.

Problems we see most often

Cycle fails at commercial scale

A cycle that works in the laboratory gives collapsed cakes or high moisture in a large dryer. Ask for scale-up and validation data, not only development results.

Freeze-dryer slots run out

Busy sites cannot fit extra batches at short notice, which delays launches and tenders. Agree annual capacity in advance.

Cakes rejected on appearance

Shrunken, cracked or collapsed cakes lead to complaints even when the drug is fine. Agree visual standards and defect limits in the specification.

Have a freeze-dried product in mind?

Send the molecule, strength, vial size, market and annual volume. We will tell you which sites fit and what data they hold.

Send your requirement Talk to our team

Other contract manufacturing

For refrigerated products see our cold-chain logistics service. Building your own brand across several products? See white label and third-party manufacturing, or the CDMO and contract manufacturing guide hub.

Frequently Asked Questions

Freeze-drying: the product is frozen in the vial, then the ice is removed under vacuum, leaving a dry cake that is dissolved before use. It keeps stable products that would otherwise break down in solution.

Because the drug is not stable enough in solution for a useful shelf life. As a dry cake it can last much longer, often at room temperature, and is reconstituted with a diluent at the point of use.

It depends on the product and fill volume. Cycles typically run from about one day to several days, which is why freeze-dryer capacity is often the limiting factor.

The solution is sterile-filtered and filled aseptically, then the partially stoppered vials are loaded into the freeze-dryer under protected conditions and stoppered inside it at the end of the cycle.

Yes, but the cycle has to be transferred and proven on the new site's equipment, with validation and stability batches and a regulatory variation in each market.

Yes. In India your company is named on the label as the marketer, alongside the manufacturer. As marketer you share responsibility with the manufacturer for quality and regulatory compliance, and you need a written agreement with it (Drugs Rules, 1945, rules 84D and 84E, in force since 1 March 2021). In export markets, that market's labelling and licence-holder rules apply.

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us